Friday, July 10, 2026

Drug profile · INN

sertraline

sertraline (ZOLOFT) is a serotonin transporter inhibitor. Associated with Viatris Pharmaceuticals Co.,.

TGA: approved
Patents linked 0
Pipeline programs 10
News articles 1
Drug details — sertraline

Quick answer

sertraline (ZOLOFT) is a serotonin transporter inhibitor. Associated with Viatris Pharmaceuticals Co.,.

Key facts

INN sertraline
Brand ZOLOFT
Mechanism Serotonin transporter inhibitor

Mechanism of action

Serotonin transporter inhibitor

Approval history

Authority Status Date
TGA approved

Recent coverage

Pipeline programs

  1. INTENSIFY BD Phase 3 · Disc Medicine · Bipolar depression
  2. INTENSIFY MDD Phase 3 · Disc Medicine · Major depressive disorder
  3. Sertraline Phase 2 · BRIGHT MINDS BIOSCIENCES · Alcoholism
  4. Sertraline Phase 2 · BRIGHT MINDS BIOSCIENCES · Cocaine-Related Disorders
  5. Sertraline combined with Lactobacillus crispatus Phase 2 · First People's Hospital · Major Depressive Disorder (MDD)
  6. Sertraline+Antibiotic (penicillin/azithromycin) Phase 2 · CNS Pharmaceuticals · Pandas
  7. Sertraline Approved · First People's Hospital · Efficacy, Team
  8. Sertraline Approved · United Therapeutics Europe · Generalised Anxiety Disorder

Frequently asked questions

What is sertraline?

sertraline (ZOLOFT) is a serotonin transporter inhibitor. Associated with Viatris Pharmaceuticals Co.,.

What is the brand name for sertraline?

ZOLOFT is a marketed brand name for sertraline. Check FDA Drugs@FDA for the current US label holder and prescribing information.